Ascendis Pharma AS (A71) — Net Asset Momentum
Ascendis Pharma AS (A71) recorded a net asset momentum of -54.0% as of December 2025, with net assets of €-162.82 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See defensive interval ratio of Ascendis Pharma AS to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Ascendis Pharma AS Net Asset Momentum (2016–2025)
This chart tracks Ascendis Pharma AS's year-over-year net asset growth across 10 annual reporting periods from 2016 to 2025. The most recent momentum reading is -54.0%, with net assets of €-162.82 Million EUR as of December 2025. Read total liabilities of Ascendis Pharma AS for a breakdown of total debt and financial obligations.
Annual Net Asset History for Ascendis Pharma AS (2016–2025)
The table below shows the complete annual net asset history for Ascendis Pharma AS from 2016 to 2025, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Ascendis Pharma AS (A71) total market value.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €-162.82 Million | €1.30 Billion | €1.47 Billion | ▼ -54.0% |
| 2024 | €-105.71 Million | €1.18 Billion | €1.29 Billion | ▲ +27.4% |
| 2023 | €-145.70 Million | €825.59 Million | €971.28 Million | ▼ -155.3% |
| 2022 | €263.35 Million | €1.09 Billion | €826.39 Million | ▼ -70.2% |
| 2021 | €883.63 Million | €1.08 Billion | €201.29 Million | ▲ +5.4% |
| 2020 | €838.71 Million | €979.79 Million | €141.08 Million | ▲ +40.5% |
| 2019 | €597.11 Million | €676.73 Million | €79.62 Million | ▲ +113.2% |
| 2018 | €280.05 Million | €318.97 Million | €38.92 Million | ▲ +49.6% |
| 2017 | €187.21 Million | €210.98 Million | €23.77 Million | ▲ +6.0% |
| 2016 | €176.61 Million | €190.07 Million | €13.46 Million | — |